Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
ALS Archives - Labiotech.eu
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma
NMD Pharma on Vimeo
Erhverv Aarhus - 照片| Facebook
NMD Pharma company information, funding & investors | Dealroom.co
Big deal: NMD flexes series A muscles - Global University Venturing
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma
NMD Pharma Information | NMD Pharma Profile
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
Neuromuscular Drug Development Summit (NMD) - Pharma Journalist
NMD Pharma brænder 41 mio. kr. af sin kæmpeinvestering
Company Presentation
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma A/S | LinkedIn
Company Presentation
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
Investors — NMD Pharma
NMD Pharma - Inkef capital
NMD Pharma company information, funding & investors | Dealroom.co
PDF) A missense mutation in the putative sarcoplasmic reticulum transmembrane protein DCST2 causes dominant strongman syndrome
NMD Pharma — NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
